(Q40685356)

22 September 2017

Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (Smallpox, monkeypox and cowpox). (English)

1 reference

22 September 2017

1 reference

1 reference

1 reference

C K Chu

1

1 reference

22 September 2017

Y H Jin

series ordinal

2

1 reference

22 September 2017

R O Baker

series ordinal

3

1 reference

22 September 2017

J Huggins

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

22 September 2017

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

22 September 2017

13

1 reference

22 September 2017

1

1 reference

22 September 2017

9-12

1 reference

Streptomyces citricolor nov. sp. and a new antibiotic, aristeromycin

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Antiviral and antimetabolic activities of neplanocins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

New neplanocin analogues. 12. Alternative synthesis and antimalarial effect of (6'R)-6'-C-methylneplanocin A, a potent AdoHcy hydrolase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Total synthesis of (-)-neplanocin a by using lithium thiolate-initiated Michael-aldol tandem cyclization reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Synthesis of carbocyclic orotidine analogs as potential orotidine decarboxylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Asymmetric synthesis and antiviral activities of L-carbocyclic 2', 3'-didehydro-2',3'-dideoxy and 2',3'-dideoxy nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Syntheses of D- and L-cyclopentenone derivatives using ring-closing metathesis: versatile intermediates for the synthesis of D- and L-carbocyclic nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Synthesis using ring closure metathesis and effect on nucleoside transport of a (N)-methanocarba S-(4-nitrobenzyl)thioinosine derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Bioterrorism: implications for the clinical microbiologist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Smallpox: clinical and epidemiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

Developing new smallpox vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900841-7

7 January 2021

10.1016/S0960-894X(02)00841-7

Identifiers

DOI

1 reference

22 September 2017

1 reference